Biotech company with anticipated key product launches.
AI-generated insights about Cura Oncology from various financial sources
The CEO made their first-ever stock purchase ahead of key product launches, indicating insider optimism about upcoming catalysts.
The CEO made their first-ever stock purchase ahead of key product launches, indicating insider optimism about upcoming catalysts.